Literature DB >> 19124679

Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.

Guido Grassi1, Gino Seravalle, Fosca Quarti-Trevano, Raffaella Dell'Oro, Francesca Arenare, Domenico Spaziani, Giuseppe Mancia.   

Abstract

The sympathetic overdrive that characterizes essential hypertension is potentiated when left ventricular hypertrophy or congestive heart failure is detected. No information exists, however, on whether this is the case also for left ventricular diastolic dysfunction. In 17 untreated hypertensive subjects with left ventricular diastolic dysfunction (age: 47.7+/-2.9 years, mean+/-SEM), we measured sympathetic nerve traffic (microneurography), heart rate (ECG), and beat-to-beat arterial blood pressure (Finapres) at rest and during baroreceptor deactivation and stimulation. Data were compared with those collected in 20 age-matched normotensive and 20 hypertensive subjects without a diastolic function impairment. Muscle sympathetic nerve traffic values were markedly and significantly greater in the 2 hypertensive groups than in the normotensive one (55.3+/-1.2 and 71.2+/-1.6 versus 41.7+/-1.0 bursts per 100 heartbeats, respectively; P<0.01 for both). For a similar blood pressure elevation, however, the sympathetic nerve traffic increase was significantly greater in patients with than without left ventricular diastolic dysfunction (+28.9%; P<0.05). In the population as a whole, muscle sympathetic nerve traffic was significantly and inversely related to various echocardiographic indices of diastolic function. Although baroreflex-heart rate control was significantly attenuated in the 2 hypertensive groups, baroreflex-sympathetic modulation was impaired only in those with diastolic dysfunction. These data provide the first evidence that, in hypertension, activation of the sympathetic nervous system may contribute not only at the blood pressure elevation but also at the development of left ventricular diastolic dysfunction. The sympathetic overactivity, which is likely to be related to the baroreflex impairment, may account for the increased cardiovascular risk characterizing diastolic dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19124679     DOI: 10.1161/HYPERTENSIONAHA.108.121467

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  49 in total

1.  Autonomic activation links CNS oxygen toxicity to acute cardiogenic pulmonary injury.

Authors:  Ivan T Demchenko; S Yu Zhilyaev; A N Moskvin; Claude A Piantadosi; Barry W Allen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-22       Impact factor: 5.464

Review 2.  Premise, promise, and potential limitations of invasive devices to treat hypertension.

Authors:  Elizabeth A Martin; Ronald G Victor
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

3.  Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.

Authors:  Liping Zhou; Adrian Filiberti; Mary Beth Humphrey; Christian D Fleming; Benjamin J Scherlag; Sunny S Po; Stavros Stavrakis
Journal:  Exp Physiol       Date:  2018-11-29       Impact factor: 2.969

4.  Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt.

Authors:  H Aceros; G Farah; L Cobos-Puc; A M Stabile; N Noiseux; S Mukaddam-Daher
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans.

Authors:  Nicole Tran; Zain Asad; Khaled Elkholey; Benjamin J Scherlag; Sunny S Po; Stavros Stavrakis
Journal:  J Cardiovasc Transl Res       Date:  2018-12-17       Impact factor: 4.132

Review 6.  Carotid baroreflex activation therapy for resistant hypertension.

Authors:  Ronald G Victor
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

7.  Habitual cigarette smoking raises pressor responses to spontaneous bursts of muscle sympathetic nerve activity.

Authors:  Jian Cui; Rachel C Drew; Matthew D Muller; Cheryl Blaha; Virginia Gonzalez; Lawrence I Sinoway
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

8.  Imaging of the Cardiac Sympathetic Nervous System Has Potential Value in the Evaluation of Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Nabil E Boutagy; Albert J Sinusas
Journal:  J Nucl Med       Date:  2017-02-23       Impact factor: 10.057

Review 9.  The sympathetic nervous system and heart failure.

Authors:  David Y Zhang; Allen S Anderson
Journal:  Cardiol Clin       Date:  2014-02       Impact factor: 2.213

Review 10.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.